Bruce Polsky is of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 65,606 shares of AVIR, which is worth approximately $218,467. The most recent transaction as insider was on Jun 20, 2024, when has been sold 17,544 shares (Common Stock) at a price of $3.49 per share, resulting in proceeds of $61,228. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.6K
0% 3M change
n/a 12M change
Total Value Held $218,467

Bruce Polsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2024
SELL
Open market or private sale
$61,228 $3.49 p/Share
17,544 Reduced 21.1%
65,606 Common Stock
Jun 16 2024
BUY
Exercise of conversion of derivative security
-
33,150 Added 28.5%
83,150 Common Stock
BP

Bruce Polsky

Boston, MA

Track Institutional and Insider Activities on AVIR

Follow Atea Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVIR shares.

Notify only if

Insider Trading

Get notified when an Atea Pharmaceuticals, Inc. insider buys or sells AVIR shares.

Notify only if

News

Receive news related to Atea Pharmaceuticals, Inc.

Track Activities on AVIR